BioNTech
advancing toward our vision once in a generation opportunity to transform medicine | BioNTech
Company
Deck Type
Sector
Industry
Deck date
August 2022
Slide
16 of 28
Similar slides by BioNTech
See diffirences between slides (animation)
Results
August 2022
advancing toward our vision | BioNTech
Investor Day
June 2022
advancing toward our long term vision | BioNTech
Investor Day
June 2022
advancing toward our long term vision | BioNTech
Related slides by other companies
Equillium
Investor Presentation
February 2024
valuable medical dermatology franchise | Equillium
AbCellera
Results
August 2023
end market is antibody medicines | AbCellera
Nuvalent
Investor Presentation
January 2024
the path to patient impact ams execute on global registrational strategies pivotal data program status study for phase ongoing with registrational intent for patients with and study for alk demonstrated clinical proof of concept in phase with planned development in both and alk for her planned phase initiation in additional discovery research programs ongoing first approved product mission bringing new best in class medicines to patients with cancer i | Nuvalent
Immatics
Investor Presentation
November 2023
interim update | Immatics
Other recent decks by BioNTech
See all presentations (12 decks)
Results
August 2022
Investor Day
June 2022
Results
March 2022
Investor Day
February 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io